Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-17-062996
Filing Date
2017-12-08
Accepted
2017-12-08 16:30:27
Documents
1
Group Members
DANIEL MACKWILMOT B. HARKEY

Document Format Files

Seq Description Document Type Size
1 SC 13G tv481066_sc13g.htm SC 13G 62535
  Complete submission text file 0001144204-17-062996.txt   64176
Mailing Address 19 OLD KINGS HIGHWAY S SUITE 200 DARIEN CT 06820
Business Address 19 OLD KINGS HIGHWAY S SUITE 200 DARIEN CT 06820 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

EIN.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89456 | Film No.: 171247452
SIC: 2834 Pharmaceutical Preparations